Multimodal Liver-Directed Management of Neuroendocrine Hepatic Metastases
Joint Authors
Source
International Journal of Hepatology
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-12, 12 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-10-29
Country of Publication
Egypt
No. of Pages
12
Main Subjects
Abstract EN
A preponderance of patients with neuroendocrine tumors (NETs) will experience hepatic metastases during the course of their disease.
Many diagnoses of NETs are made only after the neoplasms have spread from their primary gastroenteropancreatic sites to the liver.
This paper reviews current evidence-based treatments for neuroendocrine hepatic metastases, encompassing surgery, hepatic artery embolization (HAE) and chemoembolization (HACE), radioembolization, hepatic artery infusion (HAI), thermal ablation (radiofrequency, microwave, and cryoablation), alcohol ablation, and liver transplantation as therapeutic modalities.
Consideration of a multidisciplinary approach to liver-directed therapy is strongly encouraged to limit morbidity and mortality in this patient population.
American Psychological Association (APA)
Lewis, Mark A.& Hubbard, Joleen. 2011. Multimodal Liver-Directed Management of Neuroendocrine Hepatic Metastases. International Journal of Hepatology،Vol. 2011, no. 2011, pp.1-12.
https://search.emarefa.net/detail/BIM-472698
Modern Language Association (MLA)
Lewis, Mark A.& Hubbard, Joleen. Multimodal Liver-Directed Management of Neuroendocrine Hepatic Metastases. International Journal of Hepatology No. 2011 (2011), pp.1-12.
https://search.emarefa.net/detail/BIM-472698
American Medical Association (AMA)
Lewis, Mark A.& Hubbard, Joleen. Multimodal Liver-Directed Management of Neuroendocrine Hepatic Metastases. International Journal of Hepatology. 2011. Vol. 2011, no. 2011, pp.1-12.
https://search.emarefa.net/detail/BIM-472698
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-472698